Search Results - "Reindollar, R.W."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study

    Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study by Poordad, F, Bennett, M, Sepe, T.E, Cohen, E, Reindollar, R.W, Everson, G, Phillips, R.W, Siddique, A, Sullivan, J.G, Box, T.D, Fu, B, Pilot-Matias, T, Abunimeh, M, Cohen, D.E, Younes, Z

    Published in Journal of hepatology (2016)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    High Efficacy of Abt-493 and Abt-530 in Hcv Genotype 1 Infected Patients who Have Failed Direct-Acting Antiviral-Containing Regimens: The Magellan-I Study

    High Efficacy of Abt-493 and Abt-530 in Hcv Genotype 1 Infected Patients who Have Failed Direct-Acting Antiviral-Containing Regimens: The Magellan-I Study by Poordad, F, Gordon, S.C, Asatryan, A, Felizarta, F, Reindollar, R.W, Landis, C, Fried, M.W, Bernstein, D.E, Ng, T.I, Lin, C.-W, Liu, R, Kort, J, Mensa, F.J

    Published in Journal of hepatology (2016)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure

    MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure by Poordad, F, Pol, S, Asatryan, A, Buti, M, Shaw, D, Hézode, C, Lalezari, J, Felizarta, F, Reindollar, R.W, Gordon, S.C, Pianko, S, Fried, M.W, Bernstein, D.E, Gallant, J, Lin, C.-W, Lei, Y, Ng, T.I, Pilot-Matias, T, Kort, J, Mensa, F

    Published in Journal of hepatology (2017)
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    GS11 - High Efficacy of Abt-493 and Abt-530 in Hcv Genotype 1 Infected Patients who Have Failed Direct-Acting Antiviral-Containing Regimens: The Magellan-I Study

    GS11 - High Efficacy of Abt-493 and Abt-530 in Hcv Genotype 1 Infected Patients who Have Failed Direct-Acting Antiviral-Containing Regimens: The Magellan-I Study by Poordad, F., Gordon, S.C., Asatryan, A., Felizarta, F., Reindollar, R.W., Landis, C., Fried, M.W., Bernstein, D.E., Ng, T.I., Lin, C.-W., Liu, R., Kort, J., Mensa, F.J.

    Published in Journal of hepatology (2016)
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    SAT-156 - Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study

    SAT-156 - Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study by Poordad, F., Bennett, M., Sepe, T.E., Cohen, E., Reindollar, R.W., Everson, G., Phillips, R.W., Siddique, A., Sullivan, J.G., Box, T.D., Fu, B., Pilot-Matias, T., Abunimeh, M., Cohen, D.E., Younes, Z.

    Published in Journal of hepatology (2016)
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    PS-156 - MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure

    PS-156 - MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure by Poordad, F., Pol, S., Asatryan, A., Buti, M., Shaw, D., Hézode, C., Lalezari, J., Felizarta, F., Reindollar, R.W., Gordon, S.C., Pianko, S., Fried, M.W., Bernstein, D.E., Gallant, J., Lin, C.-W., Lei, Y., Ng, T.I., Pilot-Matias, T., Kort, J., Mensa, F.

    Published in Journal of hepatology (2017)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: